What is China BCT Pharmacy Group, Inc. (CNBI)?

China BCT Pharmacy Group, Inc. (CNBI) is a stock in the Healthcare sector, Medical - Pharmaceuticals industry. View full analysis on Stocks360.

What is the current price of CNBI?

The current price of CNBI is $0.00. Prices are updated in real time on Stocks360.

What is CNBI's price-to-earnings (PE) ratio?

CNBI's trailing twelve-month PE ratio is 0.00, based on current price and earnings per share data available on Stocks360.

What is CNBI's market capitalization?

CNBI's market capitalization is $686,778.00, placing it in the small-cap tier.

China BCT Pharmacy Group, Inc. (CNBI)

Stock analysis · OTC · Healthcare · Medical - Pharmaceuticals

$0.00

Market Cap

$686.78K

PE (TTM)

0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-3.86

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

60.00

China BCT Pharmacy Group, Inc. (CNBI) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $686.78K. Trailing PE 0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Mar 31, 2011

EPS $0.18 vs est. $0.19

Missed by $0.01

Proprietary Signals

Signal snapshot temporarily unavailable.

About China BCT Pharmacy Group, Inc.

China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical enterprise within the People's Republic of China, conducting its operations through various subsidiary companies. Its business activities are primarily categorized into three distinct divisions: Pharmaceutical Distribution, Retail Pharmacy, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution division procures a diverse array of medicinal goods from various suppliers, subsequently supplying them to a broad client base that includes hospitals, retail drug stores, other wholesale distributors, clinics, medical centers, and individual consumers. Its extensive inventory, numbering approximately 8,000 distinct items, encompasses both branded and generic prescription medications, over-the-counter remedies, traditional Western and Chinese medicines, personal care products, medical supplies, Chinese herbal remedies, and medical instruments. Through its Retail Pharmacy segment, the company manages a network of 196 directly owned pharmacies, predominantly located in Guangxi province, operating under the "Baicaotang" brand. These outlets provide expert pharmaceutical services and offer a broad assortment…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	0.00×
P/S (TTM)	0.00×
P/B	0.00×
P/FCF (TTM)	-0.04×
EV / EBITDA	-0.15×
EV / Sales	-0.02×
Earnings Yield	275865.43%
Free Cash Flow Yield	-2235.11%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	-$4.68M
Net Income (TTM)	$1.89B
Free Cash Flow (TTM)	-$14.50M
Net Debt	-$5.36M
Working Capital	$126.04M
Gross Margin	20.13%
Operating Margin	12.15%
Net Margin	8.70%
Return on Equity	16.79%
Return on Invested Capital	11.56%